Table of Contents
Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease.
The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries and whose products are distributed and marketed worldwide. The industry has undergone dramatic structural changes over the past few decades, with the rise of the biotechnology sector, substantial growth in demand driven by demographics and substitution away from other therapeutic modalities such as surgery, and increased competition from globally active generic manufacturers.
The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs in the United States. Drug expenditures are now the fastest-growing component of health care costs, increasing at the rate of about 15 percent per year.
Aruvian Research brings you a complete analysis of the Pharmaceutical Industry in the United States. The report covers a brief profile of the global pharmaceutical industry, an analysis of the US pharmaceutical industry, the US generic drugs industry and the US OTC pharmaceutical industry as well.
The report also analyzes the US pharmaceutical industry through two frameworks – a PEST analysis and a Porter’s Five Forces Business Strategy analysis. The report also looks at strategies for market entry, impact of the Hatch-Waxman Act, and the role of the government in the industry.
Major industry players in the industry are analyzed through an analysis of their business segments, a financial analysis and an in-depth SWOT analysis.
Complete with a comprehensive section on the research and development going on in the US pharmaceutical industry, Aruvian’s latest research is a collection of all you need to know about the US Pharmaceutical Industry.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...